Premium research materials.
Research materials only • Not for human consumption
$44.99
A GHRH analogue with drug affinity complex, studied for extended half-life in secretagogue research.
From the literature
Journal of Clinical Endocrinology & Metabolism · 2006
Albumin-binding modification extended the analogue's half-life to several days, producing sustained elevations in GH and IGF-1 after single administration in healthy subjects.
Endocrine Reviews · 2019
A review of GH secretagogue pharmacology explains why long-acting GHRH analogues are commonly studied alongside selective ghrelin receptor agonists to preserve pulsatile release.
Summaries of published literature, provided for context only. Nothing here is medical advice, and this product is sold for laboratory research use only.
Pairs well with
Triple-agonist research compound.
Dual-agonist metabolic research.
Long-acting amylin analogue.
Body protection compound.
CJC-1295 DAC
$44.99
